PATENT CLAIM ANALYSIS

Application Number: 16007047
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "465000"]

Abstract:
The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.

Claim (Index 1):
A pharmaceutical composition comprising or made from a DPP-4 inhibitor, a partner drug, and one or more pharmaceutical excipients, and a nucleophilic and/or basic agent for stabilizing said DPP-4 inhibitor against degradation.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 94.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14836996', '12935634', '12894385', '13785365', '14294630']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7466353522675911
- 35 USC 102 Novelty (BERT): 0.5988454673781929
- Combined Prediction Score: 0.7318563637786514
- Mean Citation Score: 434.15789000000007
- Max Citation Score: 601.3611
- Similarity Product: 443.8808247140944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test